| Product Code: ETC6354634 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Gene Therapy Products Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Gene Therapy Products Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Gene Therapy Products Market - Industry Life Cycle |
3.4 Belgium Gene Therapy Products Market - Porter's Five Forces |
3.5 Belgium Gene Therapy Products Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Belgium Gene Therapy Products Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Belgium Gene Therapy Products Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Belgium Gene Therapy Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in Belgium |
4.2.2 Growing investments in research and development of gene therapy products |
4.2.3 Rising adoption of personalized medicine and targeted therapies in the healthcare sector |
4.3 Market Restraints |
4.3.1 High costs associated with gene therapy products and treatments |
4.3.2 Regulatory challenges and stringent approval processes for gene therapy products in Belgium |
5 Belgium Gene Therapy Products Market Trends |
6 Belgium Gene Therapy Products Market, By Types |
6.1 Belgium Gene Therapy Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Belgium Gene Therapy Products Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Belgium Gene Therapy Products Market Revenues & Volume, By Yescarta, 2021- 2031F |
6.1.4 Belgium Gene Therapy Products Market Revenues & Volume, By Kymriah, 2021- 2031F |
6.1.5 Belgium Gene Therapy Products Market Revenues & Volume, By Luxturna, 2021- 2031F |
6.1.6 Belgium Gene Therapy Products Market Revenues & Volume, By Strimvelis, 2021- 2031F |
6.1.7 Belgium Gene Therapy Products Market Revenues & Volume, By Gendicine, 2021- 2031F |
6.2 Belgium Gene Therapy Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Belgium Gene Therapy Products Market Revenues & Volume, By Oncological Disorders, 2021- 2031F |
6.2.3 Belgium Gene Therapy Products Market Revenues & Volume, By Rare Diseases, 2021- 2031F |
6.2.4 Belgium Gene Therapy Products Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.5 Belgium Gene Therapy Products Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.6 Belgium Gene Therapy Products Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.7 Belgium Gene Therapy Products Market Revenues & Volume, By Other Diseases, 2021- 2031F |
6.3 Belgium Gene Therapy Products Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Belgium Gene Therapy Products Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Belgium Gene Therapy Products Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.4 Belgium Gene Therapy Products Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.5 Belgium Gene Therapy Products Market Revenues & Volume, By Others, 2021- 2031F |
7 Belgium Gene Therapy Products Market Import-Export Trade Statistics |
7.1 Belgium Gene Therapy Products Market Export to Major Countries |
7.2 Belgium Gene Therapy Products Market Imports from Major Countries |
8 Belgium Gene Therapy Products Market Key Performance Indicators |
8.1 Patient enrollment in gene therapy clinical trials in Belgium |
8.2 Number of partnerships and collaborations between biotech companies and research institutions in Belgium |
8.3 Increase in government funding for gene therapy research and development in Belgium |
9 Belgium Gene Therapy Products Market - Opportunity Assessment |
9.1 Belgium Gene Therapy Products Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Belgium Gene Therapy Products Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Belgium Gene Therapy Products Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Belgium Gene Therapy Products Market - Competitive Landscape |
10.1 Belgium Gene Therapy Products Market Revenue Share, By Companies, 2024 |
10.2 Belgium Gene Therapy Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here